510(k) K955596
K955596 is an FDA 510(k) premarket notification submitted by Behring Diagnostics, Inc. for the device "N LATEX B2-MICROGLOBULIN REAGENT". The FDA issued a decision of Substantially Equivalent on Oct 3, 1996. The device falls under product code JZG (System, Test, Beta-2-Microglobulin Immunological), a Class II device regulated under 21 CFR 866.5630. Behring Diagnostics, Inc. has 144 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 3, 1996
- Date Received
- Dec 8, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Beta-2-Microglobulin Immunological
- Device Class
- Class II
- Regulation Number
- 866.5630
- Review Panel
- IM
- Submission Type
- 510(k) Exempt
Need the full FDA record for Behring Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.